Literature DB >> 27940508

Persistent Pulmonary Hypertension of the Newborn in Late Preterm and Term Infants in California.

Martina A Steurer1,2, Laura L Jelliffe-Pawlowski2,3, Rebecca J Baer3,4, J Colin Partridge5, Elizabeth E Rogers5, Roberta L Keller5.   

Abstract

BACKGROUND AND OBJECTIVES: There are limited epidemiologic data on persistent pulmonary hypertension of the newborn (PPHN). We sought to describe the incidence and 1-year mortality of PPHN by its underlying cause, and to identify risk factors for PPHN in a contemporary population-based dataset.
METHODS: The California Office of Statewide Health Planning and Development maintains a database linking maternal and infant hospital discharges, readmissions, and birth and death certificates from 1 year before to 1 year after birth. We searched the database (2007-2011) for cases of PPHN (identified by International Classification of Diseases, Ninth Revision codes), including infants ≥34 weeks' gestational age without congenital heart disease. Multivariate Poisson regression was used to identify risk factors associated with PPHN; results are presented as risk ratios, 95% confidence intervals.
RESULTS: Incidence of PPHN was 0.18% (3277 cases/1 781 156 live births). Infection was the most common cause (30.0%). One-year mortality was 7.6%; infants with congenital anomalies of the respiratory tract had the highest mortality (32.0%). Risk factors independently associated with PPHN included gestational age <37 weeks, black race, large and small for gestational age, maternal preexisting and gestational diabetes, obesity, and advanced age. Female sex, Hispanic ethnicity, and multiple gestation were protective against PPHN.
CONCLUSIONS: This risk factor profile will aid clinicians identifying infants at increased risk for PPHN, as they are at greater risk for rapid clinical deterioration.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 27940508     DOI: 10.1542/peds.2016-1165

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.

Authors:  Mei-Sing Ong; Steve Abman; Eric D Austin; Jeffrey A Feinstein; Rachel K Hopper; Usha S Krishnan; Mary P Mullen; Marc D Natter; J Usha Raj; Erika B Rosenzweig; Kenneth D Mandl
Journal:  J Pediatr       Date:  2019-06-05       Impact factor: 4.406

2.  Pulmonary Hypertension Associated with Hypoxic-Ischemic Encephalopathy-Antecedent Characteristics and Comorbidities.

Authors:  Satyan Lakshminrusimha; Seetha Shankaran; Abbot Laptook; Scott McDonald; Martin Keszler; Krisa Van Meurs; Ronnie Guillet; Sanjay Chawla; Beena G Sood; Sonia Bonifacio; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2018-03-01       Impact factor: 4.406

3.  Postnatal causes and severity of persistent pulmonary Hypertension of Newborn.

Authors:  Muhammad Sohail Arshad; Mudasser Adnan; Hafiz Muhammad Anwar-Ul-Haq; Arif Zulqarnain
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

4.  Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors.

Authors:  Isabella Buffoni; Silvia Buratti; Marisa F Mallamaci; Stefano Pezzato; Elisabetta Lampugnani; Francesca Buffelli; Ezio Fulcheri; Andrea Moscatelli
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

5.  Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.

Authors:  Alvaro González; Aldo Bancalari; Waldo Osorio; Matías Luco; Agustina González; Héctor Pérez; Javier Kattan
Journal:  J Perinatol       Date:  2020-08-13       Impact factor: 2.521

6.  Association between genetic variations in carbamoyl-phosphate synthetase gene and persistent neonatal pulmonary hypertension.

Authors:  Nashwa El-Khazragy; Mohamed El Barbary; Hala Fouad; Abdallah Abdelgawad; Dina Rabie
Journal:  Eur J Pediatr       Date:  2021-03-27       Impact factor: 3.183

7.  Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

Authors:  T J Kulik; J E Lock
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

8.  Pulmonary hypertension in late onset neonatal sepsis using functional echocardiography: a prospective study.

Authors:  Sujata Deshpande; Pradeep Suryawanshi; Shrikant Holkar; Yogen Singh; Rameshwor Yengkhom; Jan Klimek; Samir Gupta
Journal:  J Ultrasound       Date:  2021-05-15

Review 9.  Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

Authors:  Yogen Singh; Satyan Lakshminrusimha
Journal:  Clin Perinatol       Date:  2021-08       Impact factor: 2.642

10.  Surf early to higher tides: surfactant therapy to optimize tidal volume, lung recruitment, and iNO response.

Authors:  Girija G Konduri; Satyan Lakshminrusimha
Journal:  J Perinatol       Date:  2020-08-13       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.